Table 1 Management and outcomes in women with uterine corpus RMS
From: Rhabdomyosarcoma of the uterus in an adult patient with osteopetrosis: a case report
References | RMS type | Age | Tumor size | Treatment | Outcome | |
|---|---|---|---|---|---|---|
1 | Oluwole | Pleomorphic | 51 years | 7 × 5.8 × 3.4 cm | TH + BSO + RPLND + resection of gross tumors | Death due to disease 0.5 months |
Fadare et al. [16] | 74 years | 14 × 6.5 × 5.1 cm | TH + BSO + PPLND + resection of gross tumors | Lost to F/U | ||
79 | 10 × 6 × 4 cm | TH + BSO + PPLND + resection of gross tumors + adj pelvic RT | Death due to disease 6.3 months | |||
68 years | 9.3 × 7.4 × 4.2 cm | TH + BSO + PPLND + resection of gross tumors + adj pelvic RT + VAC chemotherapy | Death due to disease 19 months | |||
2 | Sohsuke Yamada et al. | Embryonal | 55 years | 11 × 7 cm | TH + BSO | 6 month F/U free of disease |
3 | Garrett La et al. | Embryonal | 28 years | 5.6 cm | TH + omentectomy + VAC chemotherapy | 40 week F/U during chemo |
4 | Masaharu Fukunaga | Alveolar | 72 years | 6 cm | TH + BSO + PLND + resection of gross tumors + adj chemotherapy | Death due to disease 12 months |
5 | Masashi Takano et al. | Embryonal | 76 years | 15 × 17 cm | TH + BSO + adj chemotherapy | 10 months F/U after surgery |
6 | Carolina Chmaj et al. | Pleomorphic | 66 years | 8.2 × 6.4 cm | TH + BSO + adj chemotherapy | Death 2.5 y/s after surgery |
7 | Donkers et al. | Embryonal | 90 years | 450 gram uterus | TH + BSO | Death 7 months after surgery probably due to CHF |
Pleomorphic | 56 | 150 gruterus | TH + BSO + neoadj and adj chemoradiation | Death 6.5 y/s after surgery | ||
8 | Roberto Chiarle | Alveolar | 80 years | 9 cm | TH + BSO + adj radiotherapy | Death 4 months after surgery |
9 | Hideo Teshima et al. | Embryonal | 52 | 320 gruterus | TH + BSO + PLND + adj chemotherapy | 30 month F/U after surgery |
10 | Fabrice Leung et al. | Pleomorphic | 68 years | 5 × 5 × 2 cm | TH + BSO | 12 month F/U after surgery |
11 | Reynolds et al. | Embryonal | 65 years | 27 × 17 × 15 cm | TH + BSO + partial cystectomy + omentectomy + PLND | Death 10 days after surgery |
12 | Siegal et al. | Unavailable | 69 years | 6.1 × 5 × 4.9 cm | TH + BSO + PPLND + resection of gross tumors + adj pelvic RT | F/U 3 months after surgery |
13 | Pinto et al. [5] | Alveolar | 40 years | 12 cm | Chemotherapy | 18 month F/U after surgery |
Pleomorphic | 68 years | 13.6 cm | Chemotherapy | Death 10 months after surgery | ||
Pleomorphic | 65 years | Unavailable | Chemotherapy | 26 month F/U after surgery | ||
Pleomorphic | 62 years | 15.2 cm | Hospice care | Death 4 months after surgery | ||
Pleomorphic | 70 years | 13 cm | Chemotherapy | 9 month F/U after surgery | ||
Alveolar | 64 years | 14.5 cm | Hospice care | Death 6 weeks after surgery | ||
14 | Sara Alavi et al. | Pleomorphic | 73 years | 6.5 × 6 × 5 cm | TH + BSO | Unavailable |
15 | Norio Motoda et al. | Alveolar | 50 years | 10 cm | Partial resection | Death 19 days after surgery |
16 | Afshan Ambreen et al. | Embryonal | 22 | 8 × 10 cm | TH + BSO + adj chemoradiation | Death 14 months after surgery |
17 | Aljehani et al. | Embryonal | 54 years | 10 cm | Palliative pelvic radiotherapy | Unavailable/new case |
18 | Goldstein et al. | Unavailable | 73 years | Unavailable | TH + BSO + adj chemotherapy | 11 month F/U after surgery |
19 | Ashley S. Case et al. | Alveolar | 21 | 10.2 × 8.2 cm | TH + BSO + neoadj and adj chemotherapy | 20 month F/U after surgery |
20 | Podczaski et al. | Pleomorphic | 73 years | 10 × 7 × 5 cm | TH + BSO + omentectomy + PPLND + adj pelvic radiation | Death 3 months after surgery |
21 | Dae Woon Kim et al. | Spindle cell | 76 years | 20 × 15 × 7 cm | Subtotal hysterectomy + BSO | Death 3 months after diagnosis |
22 | Mutsumi Kuroki et al. | Unavailable | 36 years | Unavailable | Chemotherapy | Death 5 months after diagnosis |
23 | Okada et al. [7] | Pleomorphic | 53 years | 15 cm | Radical hysterectomy + adj radiation | Recurrence 2 months after surgery |
24 | Mccluggage et al. | Spindle cell | 28 years | 12 cm | Modified radical hysterectomy + PLND + adj chemoradiation | F/U 2 years after surgery |
Pleomorphic | 67 years | 5 cm | Subtotal hysterectomy + BSO | Death 3 days after surgery | ||
25 | Hart et al. [17] | Embryonal | 22 years | 100 gruterus | Radical hysterectomy + adj and neoadj chemotherapy VAC | F/U 4.4 years after surgery |
Pleomorphic | 70 years | 450 gruterus | TH + BSO | Death 4 months after surgery | ||
Pleomorphic | 56 years | Unavailable | Palliative chemotherapy | Death 6 weeks after diagnosis | ||
26 | Kevin Holcomb et al. | Pleomorphic | 63 years | 6 × 6 × 2 cm | TH + BSO | Death 4 years after surgery |
27 | S. Yeasmin et al. | Pleomorphic | 60 years | Unavailable | TH + BSO + PPLND + adj chemoradiation | Death 20 months after surgery |
28 | Jaworski et al. | Pleomorphic | 71 years | 1200 gram uterus | TH + BSO | F/U 7 months after surgery |
29 | Katalin Borka et al. | Pleomorphic | 67 years | 15 cm | TH + BSO + PPLND + adj chemotherapy | F/U 12 months after surgery |
Aminimoghaddam et al. | Alveolar | 60 years | 10 × 8 × 6 cm | TH + BSO + PPLND + neoadj chemotherapy + adj pelvic irradiation | Alive at 12 month F/U |